Sonographic discrimination of corticobasal degeneration vs proggressive supranuclear palsy

Neurology

Volumn 63, Issue 3, 2004, Pages 504-509

  Walter, Uwe ^a   Dressler, D ^a   Wolters, A ^a   Probst, T ^a   Grossmann, A ^a   Benecke, R ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN PARENCHYMA SONOGRAPHY; BRAIN THIRD VENTRICLE; CLINICAL ARTICLE; CORRELATION ANALYSIS; CORTICOBASAL DEGENERATION; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; HEARING TEST; HUMAN; IDIOPATHIC DISEASE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RANK SUM TEST; SENSITIVITY AND SPECIFICITY; STANDARDIZATION; SUBSTANTIA NIGRA; TEMPORAL BONE;

EID: 3543098625     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000133006.17909.32     Document Type: Article

References (35)

1. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
2. Lang AE, Riley DE, Bergeron C. Cortico-basal ganglionic degeneration. In: Calne DB, ed. Neurodegenerative diseases. Philadelphia: WB Saunders, 1994;877-894.
3. Litvan I, Bhatia KP, Burn DJ, et al. Movement Disorders Society Scientific Issues Committee report: SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders. Mov Disord 2003;18:467-486.
4. Litvan I, Grimes DA, Lang AE, et al. Clinical features differentiating patients with postmortem confirmed progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999;246(suppl 2):II1-5.
5. Wenning GK, Litvan I, Jankovic J, et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J Neurol Neurosurg Psychiatry 1998;64:184-189.
6. Hughes AJ, Daniel SE, Ben-Shlomo Y, Lees AJ. The accuracy of diagnosis of parkinsonian syndromes in a specialist movement disorder service. Brain 2002;125:861-870.
7. Boeve BF, Maraganore DM, Parisi JE, et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999;53:795-800.
8. Boeve B, Parisi J, Dickson D, et al. Demographic and clinical findings in 20 cases of pathologically-diagnosed corticobasal degeneration. Mov Disord 2000;15(suppl 3):228. Abstract.
9. Lang AE. Corticobasal degeneration: selected developments. Mov Disord 2003;18(suppl 6):S51-56.
10. Schrag A, Good CD, Miszkiel K, et al. Differentiation of atypical parkinsonian syndromes with routine MRI. Neurology 2000;54:697-702.
11. Dickson DW, Anderton B, Morris H, et al. International Medical Workshop covering progressive supranuclear palsy, multiple system atrophy and corticobasal degeneration. Mov Disord 2001;16:382-395.
12. Becker G, Seufert J, Bogdahn U, Reichmann H, Reiners K. Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography. Neurology 1995;45:182-184.
13. Berg D, Siefker C, Becker G. Echogenicity of the substantia nigra in Parkinson's disease and its relation to clinical findings. J Neurol 2001;248:684-689.
14. Walter U, Wittstock M, Benecke R, Dressler D. Substantia nigra echo-genicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease. J Neural Transm 2002;109:191-196.
15. Walter U, Niehaus L, Probst T, Benecke R, Meyer BU, Dressler D. Brain parenchyma sonography discriminates Parkinson's disease and atypical parkinsonian syndromes. Neurology 2003;60:74-77.
16. Naumann M, Becker G, Toyka KV, Supprian T, Reiners K. Lenticular nucleus lesion in idiopathic dystonia detected by transcranial sonography. Neurology 1996;47:1284-1290.
17. Postert T, Lack B, Kuhn W, et al. Basal ganglia alterations and brain atrophy in Huntington's disease depicted by transcranial real time sonography. J Neurol Neurosurg Psychiatry 1999;67:457-462.
18. Seidel G, Kaps M, Gerriets T, Hutzelmann A. Evaluation of the ventricular system in adults by transcranial duplex sonography. J Neuroimaging 1995;5:105-108.
19. Berg D, Maurer M, Warmuth-Metz M, Rieckmann P, Becker G. The correlation between ventricular diameter measured by transcranial sonography and clinical disability and cognitive dysfunction in patients with multiple sclerosis. Arch Neurol 2000;57:1289-1292.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
21. Mathuranath PS, Nestor PJ, Berrios GE, Rakowicz W, Hodges JR. A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia. Neurology 2000;55:1613-1620.
22. Berg D, Becker G, Zeiler B, et al. Vulnerability of the nigrostriatal system as detected by transcranial ultrasound. Neurology 1999;53:1026-1031.
23. Becker T, Becker G, Seufert J, et al. Parkinson's disease and depression: evidence for an alteration of the basal limbic system detected by transcranial sonography. J Neurol Neurosurg Psychiatry 1997;63:590-596.
24. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology 1997;48:119-125.
25. Berg D, Roggendorf W, Schroder U, et al. Echogenicity of the substantia nigra: association with increased iron content and marker for susceptibility to nigrostriatal injury. Arch Neurol 2002;56:999-1005.
26. Dexter DT, Jenner P, Schapira AH, Marsden CD. Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 1992;32(suppl):S94-100.
27. Felletschin B, Bauer P, Walter U, et al. Screening for mutations of the ferritin light and heavy genes in Parkinson's disease patients with hyperechogenicity of the substantia nigra. Neurosci Lett 2003;352:53-56.
28. Revesz T, Holton JL. Anatomopathological spectrum of tauopathies. Mov Disord 2003;18(suppl 6):S13-20.
29. Soliveri P, Monza D, Paridi D, et al. Cognitive and magnetic resonance imaging aspects of corticobasal degeneration and progressive supranuclear palsy. Neurology 1999;53:502-507.
30. Soliveri P, Monza D, Paridi D, et al. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy. J Neurol Neurosurg Psychiatry 2000;69:313-318.
31. Berg D, Naumann M, Hoggenmüller U, et al. Differences of echogenicity and T2 relaxation time of the nucleus lentiformis in MSA and PSP as compared to Parkinson's disease. Mov Disord 2000;15(suppl 3):206-207. Abstract.
32. Hardman CD, Halliday GM. The internal globus pallidus is affected in progressive supranuclear palsy and Parkinson's disease. Exp Neurol 1999;158:135-142.
33. Cordato NJ, Halliday GM, McCann H, et al. Corticobasal syndrome with tau pathology. Mov Disord 2001;16:656-667.
34. Hallgren B, Sourander P. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958;3:41-51.
35. Vymazal J, Brooks RA, Baumgarner C, et al. The relation between brain iron and NMR relaxation times: an in vitro study. Magn Reson Med 1996;35:56-61.